[Clinical utility of serum tumor markers in lung cancer].

about

[Clinical utility of serum tumor markers in lung cancer].

Item

http://www.wikidata.org/entity/Q55464875

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

[Clinical utility of serum tumor markers in lung cancer].

@en

[Clinical utility of serum tumor markers in lung cancer].

@nl

type

Item

label

[Clinical utility of serum tumor markers in lung cancer].

@en

[Clinical utility of serum tumor markers in lung cancer].

@nl

prefLabel

[Clinical utility of serum tumor markers in lung cancer].

@en

[Clinical utility of serum tumor markers in lung cancer].

@nl

P1476

[Clinical utility of serum tumor markers in lung cancer].

@en

P2093

Mengzhao Wang

http://www.w3.org/2001/XMLSchema#string

Xiao Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship

Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.

ProGRP: a new biomarker for small cell lung cancer.

Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival.

CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients.

Biomarkers for lung cancer: clinical uses.

Evaluation on the incidence, mortality and tendency of lung cancer in China.

Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death in resectable non-small cell lung cancer.

Prognostic value of serum tumor markers in patients with lung cancer.

Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer.

P304

286-291

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3779/J.ISSN.1009-3419.2011.03.16

http://www.w3.org/2001/XMLSchema#string

P407

Chinese

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21426676

http://www.w3.org/2001/XMLSchema#string

P932

5999651

http://www.w3.org/2001/XMLSchema#string